...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Events
2
Apr 25, 2017 09:48AM
5
Apr 25, 2017 10:03AM
4
Apr 25, 2017 10:35AM
1
Apr 25, 2017 02:48PM
3
Apr 25, 2017 02:57PM
1
Apr 25, 2017 03:17PM
4
Apr 25, 2017 05:28PM
5
Apr 26, 2017 12:31AM
2
Apr 26, 2017 10:51AM
Share
New Message
Please login to post a reply